TIGATX INC
Unleashing the Tumor Killing Power of Neutrophils with Engineered IgA
Boston, United States · Founded 2024
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- tigatx.com
About
TigaTx is a Boston-based biotechnology company pioneering first-in-class engineered IgA monoclonal antibodies designed to activate neutrophils to fight cancer and infectious diseases. The company received up to $35.5M in funding from ARPA-H and NIH and was acquired by Epsilogen in April 2025 to form the world's leading pan-isotype cancer antibody company.
Summary
TIGATX INC is a Biotech company based in Boston, United States, founded in 2024.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/tigatx-inc"><img src="https://indexed.vc/api/badge/company/tigatx-inc" alt="TIGATX INC on Indexed.vc" width="260" height="76" /></a>